Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 3
2016 68
2017 148
2018 137
2019 167
2020 103
2021 21
Text availability
Article attribute
Article type
Publication date

Search Results

576 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: studies
Page 1
The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis.
Farmer EK, Koren DE, Cha A, Grossman K, Cates DW. Farmer EK, et al. AIDS Patient Care STDS. 2019 May;33(5):207-213. doi: 10.1089/apc.2018.0294. AIDS Patient Care STDS. 2019. PMID: 31067124 Review.
The efficacy of pre-exposure prophylaxis (PrEP) to prevent HIV has been firmly established; however, the success of PrEP largely depends on access to care as well as high levels of medication adherence. One of the key areas of focus for the National HIV/AIDS Strategy for 2 …
The efficacy of pre-exposure prophylaxis (PrEP) to prevent HIV has been firmly established; however, the success of PrEP largely depends on …
Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color.
Wood S, Gross R, Shea JA, Bauermeister JA, Franklin J, Petsis D, Swyryn M, Lalley-Chareczko L, Koenig HC, Dowshen N. Wood S, et al. AIDS Behav. 2019 Oct;23(10):2719-2729. doi: 10.1007/s10461-019-02502-y. AIDS Behav. 2019. PMID: 30993479 Free PMC article.
Short-term and sustained adherence were measured by urine tenofovir concentration and pharmacy refills, respectively. ...Participants completed semi-structured interviews exploring adherence barriers and facilitators. Participants (n = 31) were primarily African-Ame …
Short-term and sustained adherence were measured by urine tenofovir concentration and pharmacy refills, respectively. ...Participants …
Building trust and rapport early in the new doctor-patient relationship: a longitudinal qualitative study.
Dang BN, Westbrook RA, Njue SM, Giordano TP. Dang BN, et al. BMC Med Educ. 2017 Feb 2;17(1):32. doi: 10.1186/s12909-017-0868-5. BMC Med Educ. 2017. PMID: 28148254 Free PMC article.
Our analysis of these experiences revealed five actions providers can take to reduce their patients' anxiety and build trust early in the first visit: 1) provide reassurance to patients, 2) tell patients it's okay to ask questions, 3) show patients their lab results and explain w …
Our analysis of these experiences revealed five actions providers can take to reduce their patients' anxiety and build trust early in the fi …
Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial.
Safren SA, Bedoya CA, O'Cleirigh C, Biello KB, Pinkston MM, Stein MD, Traeger L, Kojic E, Robbins GK, Lerner JA, Herman DS, Mimiaga MJ, Mayer KH. Safren SA, et al. Lancet HIV. 2016 Nov;3(11):e529-e538. doi: 10.1016/S2352-3018(16)30053-4. Epub 2016 Sep 19. Lancet HIV. 2016. PMID: 27658881 Free PMC article. Clinical Trial.
METHODS: In this three-arm randomised controlled trial in HIV-positive adults with depression, we compared CBT-AD with information and supportive psychotherapy plus adherence counselling using the Life-Steps approach (ISP-AD), and with enhanced treatment as usual (E …
METHODS: In this three-arm randomised controlled trial in HIV-positive adults with depression, we compared CBT-AD with information and suppo …
Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
Pleuhs B, Quinn KG, Walsh JL, Petroll AE, John SA. Pleuhs B, et al. AIDS Patient Care STDS. 2020 Mar;34(3):111-123. doi: 10.1089/apc.2019.0189. Epub 2020 Feb 28. AIDS Patient Care STDS. 2020. PMID: 32109141 Free PMC article.
Six themes were identified across reviewed studies: (i) a lack of PrEP knowledge, (ii) the presence of the Purview Paradox, which refers to discordance in beliefs between HIV specialists and primary care providers on who should prescribe PrEP, (iii) concerns about PrEP costs, (iv …
Six themes were identified across reviewed studies: (i) a lack of PrEP knowledge, (ii) the presence of the Purview Paradox, which refers to …
Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data.
Byrd KK, Hou JG, Hazen R, Kirkham H, Suzuki S, Clay PG, Bush T, Camp NM, Weidle PJ, Delpino A; Patient-Centered HIV Care Model Team. Byrd KK, et al. J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):245-251. doi: 10.1097/QAI.0000000000002142. J Acquir Immune Defic Syndr. 2019. PMID: 31343455 Free PMC article.
BACKGROUND: A benchmark of near-perfect adherence (95%) to antiretroviral therapy (ART) is often cited as necessary for HIV viral suppression. ...RESULTS: The adjusted odds of viral suppression did not differ between persons with an adherence level of 80% to <85% …
BACKGROUND: A benchmark of near-perfect adherence (95%) to antiretroviral therapy (ART) is often cited as necessary for HIV viral sup …
Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, Liu N, Harris DR, Mulligan K, Zimet G, Mayer KH, Anderson P, Kiser JJ, Lally M, Brothers J, Bojan K, Rooney J, Wilson CM. Hosek SG, et al. JAMA Pediatr. 2017 Nov 1;171(11):1063-1071. doi: 10.1001/jamapediatrics.2017.2007. JAMA Pediatr. 2017. PMID: 28873128 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: Adolescent Medicine Trials Network for HIV/AIDS Interventions 113 (Project PrEPare) was a PrEP demonstration project that evaluated the safety, tolerability, and acceptability of TDF/FTC and patterns of use, rates of adherence, and patter …
DESIGN, SETTING, AND PARTICIPANTS: Adolescent Medicine Trials Network for HIV/AIDS Interventions 113 (Project PrEPare) was a PrEP demonstrat …
The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting.
Pilcher CD, Ospina-Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S, Calderon F, Demicco E, Geng E, Gandhi M, Havlir DV, Hatano H. Pilcher CD, et al. J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):44-51. doi: 10.1097/QAI.0000000000001134. J Acquir Immune Defic Syndr. 2017. PMID: 27434707 Free PMC article.
Time to virologic suppression (<200 copies HIV RNA/mL) was significantly faster (median 1.8 months) among intervention-managed patients when compared with patients treated in the same clinic under prior recommendations for universal ART (4.3 months; P = 0.0001). CONCLUSIONS: …
Time to virologic suppression (<200 copies HIV RNA/mL) was significantly faster (median 1.8 months) among intervention-managed patients w …
576 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page